Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a ‘Buy’ rating, citing the strength of the company’s US pipeline as a major growth driver. Jefferies raised its target price to Rs 1,450 from Rs 1,210, indicating a 30% upside from the previous closing price of Rs 1,113.80.
SpiceJet shares rise 13%, extending second-day rally amid IndiGo operational disruptions
SpiceJet shares spiked intraday as operational disruptions at rival IndiGo boosted demand for its services. Despite the short-term rally, the stock remains fundamentally weak, with